Novo Seeds expands company formation activities at BiOrigin with seasoned entrepreneurs
- Martin Bonde, John Haurum and Anders Hinsby join as Entrepreneurs-in-Residence
- Peter Hirth and Anders Gersel Pedersen join as Advisors
Novo Seeds, the early stage investment arm of Novo Holdings, wholly owned by the Novo Nordisk Foundation, today announced that its advisory unit, BiOrigin, has appointed several seasoned entrepreneurs to its team. Former executives Martin Bonde of Vaccibody, John Haurum of F-star, and Anders Hinsby of Orphazyme join BiOrigin as Entrepreneurs-in-Residence. Peter Hirth, co-founder and former CEO of Plexxikon, and Anders Gersel Pedersen, former EVP of Research and Development of Lundbeck, join as Advisors.
